Literature DB >> 22226600

Immune responses of microglia in the spinal cord: contribution to pain states.

Dominic Schomberg1, Julie K Olson.   

Abstract

The role of microglia and their contribution to the development and maintenance of pain states has emerged as an attractive field of study. Sensitization of central nociceptors and interneurons is thought to be responsible for the symptoms of chronic neuropathic pain states. Microglia interact with these neurons at the site of injury or disease as well as remotely. Microglia can be activated by phagocytosis or through the activation of a number of constitutively expressed cell surface molecules. Once activated, microglia participate in both innate and adaptive immune responses and remain active indefinitely. Activated microglia contribute to pain states through the production of pro-inflammatory cytokines, chemokines and extracellular proteases. Activated microglia also exhibit a modulated cell surface receptor and ion channel profile. The activation of several intracellular pathways in microglia has also been implicated in pain states. Attenuation of microglia activity is being presented as a viable therapeutic approach with regard to not only the reduction of pain symptoms but also in preventing the development of chronic pain states. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22226600     DOI: 10.1016/j.expneurol.2011.12.021

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  37 in total

1.  LRP1 deficiency in microglia blocks neuro-inflammation in the spinal dorsal horn and neuropathic pain processing.

Authors:  Coralie Brifault; HyoJun Kwon; Wendy M Campana; Steven L Gonias
Journal:  Glia       Date:  2019-02-11       Impact factor: 7.452

Review 2.  The role of microglia in chronic pain and depression: innocent bystander or culprit?

Authors:  Nan Yin; Enshi Yan; Wenbin Duan; Changyuan Mao; Qin Fei; Chun Yang; Yimin Hu; Xiaolin Xu
Journal:  Psychopharmacology (Berl)       Date:  2021-02-05       Impact factor: 4.530

3.  Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.

Authors:  Natalie M Guley; Nobel A Del Mar; Tyler Ragsdale; Chunyan Li; Aaron M Perry; Bob M Moore; Marcia G Honig; Anton Reiner
Journal:  Exp Eye Res       Date:  2019-03-26       Impact factor: 3.467

Review 4.  Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets.

Authors:  P Boadas-Vaello; S Castany; J Homs; B Álvarez-Pérez; M Deulofeu; E Verdú
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

Review 5.  Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.

Authors:  Dominic Schomberg; Gurwattan Miranpuri; Tyler Duellman; Andrew Crowell; Raghu Vemuganti; Daniel Resnick
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

6.  sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain.

Authors:  Dan Kaufmann; Peter J West; Misty D Smith; Boris Yagen; Meir Bialer; Marshall Devor; H Steve White; K C Brennan
Journal:  Pharmacol Res       Date:  2016-11-24       Impact factor: 7.658

7.  Spinal microglial activation in a murine surgical model of knee osteoarthritis.

Authors:  P B Tran; R E Miller; S Ishihara; R J Miller; A M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2016-09-16       Impact factor: 6.576

Review 8.  Neural mechanisms underlying the pain of juvenile idiopathic arthritis.

Authors:  Luke La Hausse de Lalouvière; Yiannis Ioannou; Maria Fitzgerald
Journal:  Nat Rev Rheumatol       Date:  2014-02-04       Impact factor: 20.543

Review 9.  Opioid administration following spinal cord injury: implications for pain and locomotor recovery.

Authors:  Sarah A Woller; Michelle A Hook
Journal:  Exp Neurol       Date:  2013-03-15       Impact factor: 5.330

10.  Effects of intrathecal carbenoxolone treatment on nociception and analgesia in rat.

Authors:  Marjan Kamalpour; Masoud Fereidoni; Ali Moghimi
Journal:  Balkan Med J       Date:  2014-06-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.